Association of albuminuria and the metabolic syndrome

Current Diabetes Reports

Volumn 3, Issue 1, 2003, Pages 80-86

  Rowley, Kevin ^b   O'Dea, Kerin ^a   Best, James D ^b  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; DIET; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DYSLIPIDEMIA; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE; METABOLIC SYNDROME X; MORTALITY; NONHUMAN; OBESITY; OXIDATION; PRENATAL DISORDER; PROTEINURIA; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM; ALBUMINURIA; FEMALE; LONGITUDINAL STUDY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE;

ALBUMINURIA; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; LIFE STYLE; LONGITUDINAL STUDIES; METABOLIC SYNDROME X; OXIDATIVE STRESS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 0037312052     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-003-0058-1     Document Type: Review

References (52)

1. Gerstein HC, Mann JFE, Yi Q, et al.: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001, 286:421-426.
2. Roest M, Banga JD, Janssen WMT, et al.: Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 2001, 103:3057-3061.
3. Liese AD, Mayer-Davis J, Haffner SM: Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 1998, 20:157-172.
4. Isomaa B, Almgren P, Tuomi T, et al.: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689.
5. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M: Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. Circulation 1995, 91:831-837.
6. Alberti KGMM, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Diabet Med 1998, 15:539-553.
7. Isomaa B, Henricsson M, Almgren P, et al.: The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 2001, 44:1148-1154.
8. Meigs JB, Jacques PF, Selhub J, et al.: Fasting plasma homocysteine levels in the insulin resistance syndrome. Diabetes Care 2001, 24:1403-1410.
9. Hodge AM, Dowse GK, Zimmet PZ: Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus. Diabet Med 1996, 13:441-449.
10. Jager A, Kostense PJ, Nijpels G, et al.: Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn study. Diabetologia 1998, 41:694-700.
11. Mykkänen L, Zaccaro DJ, Wagenknecht LE, et al.: Microalbuminuria is associated with insulin resistance in nondiabetic subjects. The Insulin Resistance Atherosclerosis Study. Diabetes 1998, 47:793-800.
12. Xu Z-R, Molyneaux L, Wang Y-Z, et al.: Clustering of cardiovascular risk factors with diabetes in Chinese patients: the effects of sex and hyperinsulinaemia. Diabetes Obes Metab 2001, 3:157-162.
13. Rowley KG, Iser DM, Best JD, et al.: Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndrome. Diabetologia 2000, 43:1397-1403.
14. Hoy W, Jim S, Warrington W, et al.: Urinary findings and renal function in adult Navajo Indians and associations with type 2 diabetes. Am J Kidney Dis 1996, 28:339-349.
15. Hoy WE, Mathews JD, McCredie DA, et al.: The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int 1998, 54:1296-1304.
16. Goetz FC, Jacobs DR, Chavers B, et al.: Risk factors for kidney damage in the adult population of Wadena, Minnesota. Am J Epidemiol 1997, 145:91-102.
17. Go RC, Desmond R, Roseman JM, et al.: Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes. Diabetes Care 2001, 24:1764-1769.
18. Kim YI, Kim CH, Choi CS, et al.: Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes Res Clin Pract 2001, 52:145-152.
19. Yudkin JS, Martyn CN, Phillips DI, Gale CR: Associations of micro-albuminuria with intra-uterine growth retardation. Nephron 2001, 89:309-314.
20. Hoy WE, Rees M, Kile E, et al.: Low birthweight and renal disease in Australian Aborigines. Lancet 1998, 352:1826-1827.
21. Pannacciulli N, Cantatore FP, Minenna A, et al.: Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women. J Intern Med 2001, 250:502-507.
22. Toft I, Bonaa KH, Eikrem J, et al.: Microalbuminuria in hypertension is not a determinant of insulin resistance. Kidney Int 2002, 61:1445-1452.
23. Monster TB, Janssen WM, de Jong PE, et al.: The impact of antihypertensive drug groups on urinary albumin excretion in a non-diabetic population. Brit J Clin Pharmacol 2002, 53:31-36.
24. Srinivasan SR, Myers L, Berenson GS: Risk variables of insulin resistance syndrome in African-American and Caucasian young adults with microalbuminuria: the Bogalusa Heart Study. Am J Hypertens 2000, 13:1274-1279.
25. Beisswenger PJ, Makita Z, Curphey TJ, et al.: Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 1995, 44:824-829.
26. Keane WK: Nephrology forum: lipids and the kidney. Kidney Int 1994, 46:910-920.
27. Svensson M, Eriksson JW: No direct link between albumin excretion rate and insulin resistance - a study in type 1 diabetes patients with mild nephropathy. Horm Metab Res 2002, 34:254-259.
28. Wiggam MI, Hunter SJ, Ennis CN, et al.: Insulin action and skeletal muscle blood flow in patients with type 1 diabetes and microalbuminuria. Diab Res Clin Pract 2001, 53:73-83.
29. Rowley KG, Best JD, O'Dea K: The relationship of insulin resistance to metabolic syndrome components varies across population groups. Annual Scientific Meeting of the Australian Diabetes Society and the Australian Diabetes Educators Association. Adelaide, Australia: 2002:110.
30. Fujikawa R, Okubo M, Egusa G, Kohno N: Insulin resistance precedes the appearance of albuminuria in non-diabetic subjects: 6 years follow up study. Diabet Res Clin Nact 2001, 53:99-106.
31. Smulders YM, Rakic M, Stehouwer CDA, et al.: Determinants of progression of microalbuminuria in patients with NIDDM. Diabetes Care 1997, 20:999-1005.
32. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [no authors listed]. Kidney Int 1995, 47:1703-1720.
33. Nelson RG, Morgenstern H, Bennett PH: Birth weight and renal disease in Pima Indians with type 2 diabetes mellitus. Am J Epidemiol 1998, 148:650-656.
34. Vestbo E, Damsgaard EM, Froland A, Mogensen CE: Birth weight and cardiovascular risk factors in an epidemiological study. Diabetologia 1996, 39:1598-1602.
35. Hinchlifle SA, Lynch MR, Sargent PH, et al.: The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 1992, 99:296-301.
36. Phillips DIW: Insulin resistance as a programmed response to fetal undernutrition. Diabetologia 1996, 39:1119-1122.
37. Rowley KG, Su Q, O'Dea K, et al. The association of plasma carotenoids with albuminuria in several Australian population groups. Proc Aust Physiol Pharmacol Soc 2001, 32(suppl 2):45P.
38. Mollsten AV, Dahlquist GG, Stattin EL, Rudberg S: Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type 1 diabetic patients. Diabetes Care 2001, 24:805-810.
39. Olsen SF, Olsen J, Frische G: Does fish consumption during pregnancy increase fetal growth? A study of the size of the newborn, placental weight and gestational age in relation to fish consumption during pregnancy. Int J Epidemiol 1990, 19:971-977.
40. Hofmann MA, Schiekofer S, Isermann B, et al.: Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB. Diabetologia 1999, 42:222-232.
41. Karkar AM, Smith JC, Pusey CD: Prevention and treatment of experimental cresentic glomerulonephritis by blocking tumour necrosis factor-alpha. Nephrol Dial Transplant 2001, 16:518-524.
42. Navarro JF, Mora C: Antiproteinuric effect of pentoxyfilline in patients with diabetic nephropathy [letter]. Diabetes Care 1999, 22:1006-1007.
43. Festa A, D'Agostino R, Howard G, et al.: Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study. Kidney Int 2000, 58:1703-1710.
44. McAuliffe AV, Brooks BA, Fisher EJ, et al.: Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: effect on urinary albumin excretion. Nephron 1998, 80:277-284.
45. Morcos M, Borcea V, Isermann B, et al.: Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract 2001, 52:175-183.
46. Arcaro G, Cretti A, Balzano S, et al.: Insulin causes endothelial dysfunction in humans. Sites and mechanisms. Circulation 2002, 105:576-582.
47. Khan BV, Navalkar S, Khan QA, et al.: Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease. J Am Coll Cardiol 2001, 38:1662-1667.
48. Nannipieri M, Penno G, Rizzo L, et al.: Transcapillary escape rate of albumin in type II diabetic patients. The relationship with microalbuminuria and hypertension. Diabetes Care 1997, 20:1019-1026.
49. Clausen P, Jensen JS, Jensen G, et al.: Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001, 103:1869-1874.
50. Wong M, Toh L, Wilson AM, et al. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum 2003, in press.
51. Tan KCB, Chow W-S, Ai VHG, et al.: Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 2002, 25:1055-1059.
52. Stehouwer CDA, Lambert J, Donker AJM, van Hinsbergh VWM: Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997, 34:55-68.